Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interface‐based design of the favipiravir‐binding site in SARS‐CoV‐2 RNA‐dependent RNA polymerase reveals mutations conferring resistance to chain termination
Aditya K. Padhi, Jagneshwar Dandapat, Prakash Saudagar, et al.
FEBS Letters (2021) Vol. 595, Iss. 18, pp. 2366-2382
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Oral antiviral treatments for COVID-19: opportunities and challenges
Laila Rahmah, Sunny O. Abarikwu, Amanuel Godana Arero, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1255-1278
Open Access | Times Cited: 70
Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach
Taj Mohammad, Arunabh Choudhury, Insan Habib, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 58
Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity
Ikbel Hadj Hassine, Manel Ben M’hadheb-Gharbi, Luis Menéndez‐Arias
Viruses (2022) Vol. 14, Iss. 4, pp. 841-841
Open Access | Times Cited: 42
Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes
Aditya K. Padhi, Timir Tripathi
Biochemical and Biophysical Research Communications (2022) Vol. 629, pp. 54-60
Open Access | Times Cited: 35
Computational Protein Design for COVID-19 Research and Emerging Therapeutics
Parismita Kalita, Timir Tripathi, Aditya K. Padhi
ACS Central Science (2023) Vol. 9, Iss. 4, pp. 602-613
Open Access | Times Cited: 15
Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern
Luca Murer, Romain Volle, Vardan Andriasyan, et al.
Current Research in Virological Science (2022) Vol. 3, pp. 100019-100019
Open Access | Times Cited: 26
Antivirals for Broader Coverage against Human Coronaviruses
Mia Outteridge, Christine M. Nunn, Kevin M. Devine, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 156-156
Open Access | Times Cited: 4
An integrated understanding of the evolutionary and structural features of the SARS-CoV-2 spike receptor binding domain (RBD)
Dwipanjan Sanyal, Suharto Banerjee, Aritra Bej, et al.
International Journal of Biological Macromolecules (2022) Vol. 217, pp. 492-505
Open Access | Times Cited: 17
Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function
Sk. Sarif Hassan, Kenneth Lundström, Ángel Serrano‐Aroca, et al.
International Journal of Biological Macromolecules (2021) Vol. 194, pp. 128-143
Open Access | Times Cited: 20
Revealing the structural and molecular interaction landscape of the favipiravir-RTP and SARS-CoV-2 RdRp complex through integrative bioinformatics: Insights for developing potent drugs targeting SARS-CoV-2 and other viruses
Chiranjib Chakraborty, Manojit Bhattacharya, Abinit Saha, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 7, pp. 1048-1056
Open Access | Times Cited: 7
Drug-Based Therapeutic Strategies for COVID-19-Infected Patients and Their Challenges
Khatereh Zarkesh, Elaheh Entezar-Almahdi, Parisa Ghasemiyeh, et al.
Future Microbiology (2021) Vol. 16, Iss. 18, pp. 1415-1451
Open Access | Times Cited: 16
African derived phytocompounds may interfere with SARS-CoV-2 RNA capping machinery via inhibition of 2′-O-ribose methyltransferase: An in silico perspective
Gideon Ampoma Gyebi, Oludare M. Ogunyemi, Adedotun A. Adefolalu, et al.
Journal of Molecular Structure (2022) Vol. 1262, pp. 133019-133019
Open Access | Times Cited: 11
Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction
Akiko Ogawa, Seiya Ohira, Yuri Kato, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Interface‐Guided Computational Protein Design Reveals Bebtelovimab‐Resistance Mutations in SARS‐CoV‐2 RBD: Correlation with Global Viral Genomes and Bebtelovimab‐Escape Mutations
Shweata Maurya, S Rajesh Kumar, Aditya K. Padhi
ChemistrySelect (2023) Vol. 8, Iss. 46
Closed Access | Times Cited: 6
A comprehensive protein design protocol to identify resistance mutations and signatures of adaptation in pathogens
Aditya K. Padhi, Timir Tripathi
Briefings in Functional Genomics (2022) Vol. 22, Iss. 2, pp. 195-203
Closed Access | Times Cited: 9
Application of Omics and Bioinformatics Technologies in Response to COVID-19 Pandemic
Abebe Mengesha Aga, Adugna Abdi Woldesemayat
Molecular and Cellular Biomedical Sciences (2024) Vol. 8, Iss. 1, pp. 1-1
Open Access | Times Cited: 1
From De Novo Design to Redesign: Harnessing Computational Protein Design for Understanding SARS-CoV-2 Molecular Mechanisms and Developing Therapeutics
Aditya K. Padhi, Parismita Kalita, Shweata Maurya, et al.
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 41, pp. 8717-8735
Closed Access | Times Cited: 4
Recent Advances in Influenza, HIV and SARS-CoV-2 Infection Prevention and Drug Treatment—The Need for Precision Medicine
Tamás Kálai, Judit E. Pongrácz, Péter Mátyus
Chemistry (2022) Vol. 4, Iss. 2, pp. 216-258
Open Access | Times Cited: 7
High-throughput design of symmetrical dimeric SARS-CoV-2 main protease: structural and physical insights into hotspots for adaptation and therapeutics
Aditya K. Padhi, Timir Tripathi
Physical Chemistry Chemical Physics (2022) Vol. 24, Iss. 16, pp. 9141-9145
Closed Access | Times Cited: 7
Two years into COVID‐19 – Lessons in SARS‐CoV‐2 and a perspective from papers in FEBS Letters
Urs F. Greber
FEBS Letters (2021) Vol. 595, Iss. 23, pp. 2847-2853
Open Access | Times Cited: 5
Uncovering the secrets of resistance: An introduction to computational methods in infectious disease research
Aditya K. Padhi, Shweata Maurya
Advances in protein chemistry and structural biology (2024), pp. 173-220
Closed Access
Interface design of SARS-CoV-2 symmetrical nsp7 dimer and machine learning-guided nsp7 sequence prediction reveals physicochemical properties and hotspots for nsp7 stability, adaptation, and therapeutic design
Amar Jeet Yadav, S Rajesh Kumar, Shweata Maurya, et al.
Physical Chemistry Chemical Physics (2024) Vol. 26, Iss. 18, pp. 14046-14061
Closed Access
SARS-CoV-2 Resistance to Small Molecule Inhibitors
Uxua Modrego Lopez, Md Mehedi Hasan, Brandon Havranek, et al.
Current Clinical Microbiology Reports (2024) Vol. 11, Iss. 3, pp. 127-139
Open Access
Antivirals and Biologics for Broader Coverage Against Human Coronaviruses
Mia Outteridge, Christine M. Nunn, Kevin M. Devine, et al.
(2023)
Open Access | Times Cited: 1
Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes
Aditya K. Padhi, Timir Tripathi
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top